The exercise period for warrants of series TO 6 B begins today
Lund, Sweden - Today is the first day of the exercise period for Clinical Laserthermia Systems AB's ("CLS" or the "Company") warrants of series TO 6 B, which was issued in connection with the Company's rights issue of units which was resolved by the extraordinary general meeting on June 8, 2023. Holders of warrants of series TO 6 B have, for each warrant, the right to subscribe for one (1) new B-share in CLS at a price of SEK 0.10 per share. The exercise period runs until and including February 6, 2024.Information about warrants of series TO 6 B In connection with the Company's